PLOD1 and polycystic ovary syndrome: found a “metabolic” subtype of PCOS that was characterized by enhanced BMI, glucose, and insulin levels with lower SHBG and LH levels in an unsupervised, phenotypic clustering analysis with similar features as our IR-PCOS patients (35).